Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Otitis media and the new guidelines.

Margaret A Kenna1

  • 1Department of Otolaryngology and Communication Disorders, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. margaret.kenna@childrens.haward.edu

The Journal of Otolaryngology
|August 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Prenatal Expanded Genetic Carrier Screening Results for Autosomal Recessive Sensorineural Hearing Loss.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2024
Same author

Microbial DNA extraction method for avian feces and preen oil from diverse species.

Ecology and evolution·2024
Same author

Chromosomal structural rearrangements implicate long non-coding RNAs in rare germline disorders.

Human genetics·2024
Same author

Rare germline disorders implicate long non-coding RNAs disrupted by chromosomal structural rearrangements.

medRxiv : the preprint server for health sciences·2024
Same author

PKHD1L1, a gene involved in the stereocilia coat, causes autosomal recessive nonsyndromic hearing loss.

Human genetics·2024
Same author

<i>PKHD1L1</i>, A Gene Involved in the Stereocilia Coat, Causes Autosomal Recessive Nonsyndromic Hearing Loss.

medRxiv : the preprint server for health sciences·2023

New guidelines for acute otitis media (AOM) and otitis media with effusion (OME) emphasize watchful waiting for AOM and updated management for OME. Clinical judgment remains crucial for otitis media treatment decisions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Practice Guidelines

Background:

  • Otitis media, encompassing recurrent acute otitis media (AOM) and otitis media with effusion (OME), is a frequent reason for pediatric primary care visits.
  • Historically, antibacterial therapy was the standard treatment for AOM and often OME.
  • Previous guidelines in 1994 for OME influenced management, leading to revised evidence-based guidelines in 2004 for both OME and AOM.

Purpose of the Study:

  • To review current knowledge on AOM and OME.
  • To discuss the 2004 evidence-based clinical practice guidelines for AOM and OME.
  • To highlight the importance of clinical judgment in otitis media management.

Main Methods:

  • Review of current scientific knowledge on AOM and OME.

Related Experiment Videos

  • Point-by-point discussion of the 2004 AOM and OME clinical practice guidelines.
  • Consideration of factors influencing treatment decisions beyond guidelines.

    • Main Results:

    • The 2004 AOM guideline recommends watchful waiting without antibiotics for specified situations, acknowledging spontaneous resolution.
    • The 2004 OME guideline expanded applicability to children aged 2 months to 12 years, including those with special conditions.
    • Surgical recommendations were included for OME but not for AOM.

    Conclusions:

    • Clinical practice guidelines provide a framework but do not replace clinical judgment for otitis media management.
    • Patient-specific factors like illness severity, underlying conditions, and follow-up access are critical.
    • Further studies are needed to evaluate the efficacy of the 2004 guidelines in diverse pediatric populations.